- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01619930
The Effects of Behavioral Activation and Physical Exercise on Depression
The Effects on Depression of Internet-administered Behavioural Activation and Physical Exercise With Treatment Rationale and Relapse Prevention: Study Protocol for a Randomised Controlled Trial
Study Overview
Status
Conditions
Detailed Description
BACKGROUND:
Despite their potential as low-threshold, low-cost and high-flexibility treatments of depression, behavioural activation and physical exercise have not yet been directly compared. This study will examine the effects of these interventions, administered via the Internet. The added effect of providing a treatment rationale will also be studied, as well as a relapse prevention program featuring cognitive behavioural therapy components.
METHODS/DESIGN:
This randomised controlled trial will include 500 participants meeting the diagnostic criteria for major depression, recruited in multiple cycles and randomised to either a waiting list control group with delayed treatment, or one of the four treatment groups: (1) physical exercise without a clear treatment rationale; (2) physical exercise with treatment rationale; (3) behavioural activation with treatment rationale; or (4) behavioural activation without a clear treatment rationale. Post treatment, half of the participants will be offered a relapse prevention program. Primary outcome measure will be the Patient Health Questionnaire 9-item. Secondary measures include diagnostic criteria for depression, as well as self-reported anxiety, physical activity and quality of life. Measurements - done via telephone and the Internet - will be collected pre-treatment, weekly during treatment period, immediately post treatment and then monthly during a 24-month follow-up period.
DISCUSSION:
The results of this study will constitute an important contribution to the body of knowledge of the respective interventions.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Västerbotten
-
Umeå, Västerbotten, Sweden, 90181
- Department of Psychology, Umeå University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Satisfy DSM-IV (or DSM-V) criteria for depression, with depression being primary diagnosis
- Scoring within the interval 15-35 on the Montgomery-Åsberg Depression Rating Scale (MADRS)
- Living in Sweden and being able to read Swedish
- Access to computer with internet connection
Exclusion Criteria:
- Currently receiving other psychological treatment
- Non-stable use of psychoactive medication
- Deemed to suffer from a too severe depression
- Deemed to suffer from other psychological disorder, e.g. psychosis, bipolarity etc.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1a
In phase 1, group 1 undergoes physical activation without added motivation interviewing. Post-treatment (phase 2), group 1 is divided by randomization into group 1a and 1b, where 1a receives relapse prevention and 1b does not. Both 1a and 1b undergo post-treatment measurements as previously described. n = 50 + 12 = 62 (50 from group 1 + 12 from waiting list control group) |
Focus is on physical exercise, motivated by research findings that it has a positive effect on depressive symptoms.
An individualized exercise program is constructed, to be followed by the respective participant.
A user-friendly pulse watch will be mailed to participants.
Exercise is monitored through online self-registration with automated feedback.
|
|
Experimental: 1b
In phase 1, group 1 undergoes physical activation without added motivation interviewing. Post-treatment (phase 2), group 1 is divided by randomization into group 1a and 1b, where 1a receives relapse prevention and 1b does not. Both 1a and 1b undergo post-treatment measurements as previously described. n = 50 + 12 = 62 (50 from group 1 + 12 from waiting list control group) |
Focus is on physical exercise, motivated by research findings that it has a positive effect on depressive symptoms.
An individualized exercise program is constructed, to be followed by the respective participant.
A user-friendly pulse watch will be mailed to participants.
Exercise is monitored through online self-registration with automated feedback.
|
|
Experimental: 2a
In phase 1, group 2 undergoes physical activation with added motivation interviewing. Post-treatment (phase 2), group 2 is divided by randomization into group 2a and 2b, where 2a receives relapse prevention and 2b does not. Both 2a and 2b undergo post-treatment measurements as previously described. n = 50 + 12 = 62 (50 from group 2 + 12 from waiting list control group) |
Focus is on physical exercise, motivated by research findings that it has a positive effect on depressive symptoms.
An individualized exercise program is constructed, to be followed by the respective participant.
A user-friendly pulse watch will be mailed to participants.
Exercise is monitored through online self-registration with automated feedback.
An initial motivational interview (MI) per telephone is also conducted, to explore the intrinsic motivation to change in participants.
|
|
Experimental: 2b
In phase 1, group 2 undergoes physical activation with added motivation interviewing. Post-treatment (phase 2), group 2 is divided by randomization into group 2a and 2b, where 2a receives relapse prevention and 2b does not. Both 2a and 2b undergo post-treatment measurements as previously described. n = 50 + 12 = 62 (50 from group 2 + 12 from waiting list control group) |
Focus is on physical exercise, motivated by research findings that it has a positive effect on depressive symptoms.
An individualized exercise program is constructed, to be followed by the respective participant.
A user-friendly pulse watch will be mailed to participants.
Exercise is monitored through online self-registration with automated feedback.
An initial motivational interview (MI) per telephone is also conducted, to explore the intrinsic motivation to change in participants.
|
|
Experimental: 3a
In phase 1, group 3 undergoes behavioral activation with added motivation interviewing. Post-treatment (phase 2), group 3 is divided by randomization into group 3a and 3b, where 3a receives relapse prevention and 3b does not. Both 3a and 3b undergo post-treatment measurements as previously described. n = 50 + 12 = 62 (50 from group 3 + 12 from waiting list control group) |
A behavioral activation program, based on the TRAP-TRAC model according to which suffering individuals are trapped in a vicious circle of avoidance and ever fewer reinforcers, leading to increasing discomfort.
To break free of this vicious circle, patients have to replace avoidance patterns with alternative coping strategies.
Unlike previous applications of this program done in the U.S., this study will feature an internet-based administration.
Approximately 15 minutes of electronic therapist support will be included per week.
|
|
Experimental: 3b
In phase 1, group 3 undergoes behavioral activation with added motivation interviewing. Post-treatment (phase 2), group 3 is divided by randomization into group 3a and 3b, where 3a receives relapse prevention and 3b does not. Both 3a and 3b undergo post-treatment measurements as previously described. n = 50 + 12 = 62 (50 from group 3 + 12 from waiting list control group) |
A behavioral activation program, based on the TRAP-TRAC model according to which suffering individuals are trapped in a vicious circle of avoidance and ever fewer reinforcers, leading to increasing discomfort.
To break free of this vicious circle, patients have to replace avoidance patterns with alternative coping strategies.
Unlike previous applications of this program done in the U.S., this study will feature an internet-based administration.
Approximately 15 minutes of electronic therapist support will be included per week.
|
|
Experimental: 4a
In phase 1, group 4 undergoes behavioral activation without added motivation interviewing. Post-treatment (phase 2), group 4 is divided by randomization into group 4a and 4b, where 4a receives relapse prevention and 4b does not. Both 4a and 4b undergo post-treatment measurements as previously described. n = 50 + 12 = 62 (50 from group 4 + 12 from waiting list control group) |
A behavioral activation program without TRAP-TRAC rationale, but with some encouragement provided ("Activate yourself and feel better!").
Approximately 15 minutes of electronic therapist support will be included per week.
|
|
Experimental: 4b
In phase 1, group 4 undergoes behavioral activation with added motivation interviewing. Post-treatment (phase 2), group 4 is divided by randomization into group 4a and 4b, where 4a receives relapse prevention and 4b does not. Both 4a and 4b undergo post-treatment measurements as previously described. n = 50 + 12 = 62 (50 from group 4 + 12 from waiting list control group) |
A behavioral activation program without TRAP-TRAC rationale, but with some encouragement provided ("Activate yourself and feel better!").
Approximately 15 minutes of electronic therapist support will be included per week.
|
|
No Intervention: Phase 1 Waiting list control group
Control group during phase 1, in parallel with treatment groups 1-4.
Weekly self-report measurements, the results of which are conveyed in the form of individualized feedback.
After 12 weeks, the participants of the control group (n = 100) are randomized to one four phase 1 active treatment groups (1-4) and receive treatment accordingly.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in Patient Health Questionnaire (PHQ-9)
Time Frame: 24 hours
|
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire.
The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment.
The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
|
24 hours
|
|
Change from baseline in Patient Health Questionnaire (PHQ-9)
Time Frame: 12 months
|
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire.
The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment.
The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
|
12 months
|
|
Change from baseline in Patient Health Questionnaire (PHQ-9)
Time Frame: 24 months
|
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire.
The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment.
The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
|
24 months
|
|
Change from baseline in Patient Health Questionnaire (PHQ-9)
Time Frame: Weekly during treatment period of 12 weeks
|
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire.
The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment.
The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
|
Weekly during treatment period of 12 weeks
|
|
Change from baseline in Patient Health Questionnaire (PHQ-9)
Time Frame: Monthly, 0-24 months
|
The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire.
The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment.
The PHQ-9 is based directly on the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual Fourth Edition (DSM-IV).
|
Monthly, 0-24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in Quality Of Life Inventory (QOLI)
Time Frame: 24 hours
|
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play.
The QOLI test is a measure of positive psychology and positive mental health.
|
24 hours
|
|
Change from baseline in Quality Of Life Inventory (QOLI)
Time Frame: 12 months
|
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play.
The QOLI test is a measure of positive psychology and positive mental health.
|
12 months
|
|
Change from baseline in Quality Of Life Inventory (QOLI)
Time Frame: 24 months
|
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play.
The QOLI test is a measure of positive psychology and positive mental health.
|
24 months
|
|
Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: 24 hours
|
7-item screening form for Generalized Anxiety Disorder.
|
24 hours
|
|
Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: 12 months
|
7-item screening form for Generalized Anxiety Disorder.
|
12 months
|
|
Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: 24 months
|
7-item screening form for Generalized Anxiety Disorder.
|
24 months
|
|
Change from baseline in the International Physical Activity Questionnaire (IPAQ)
Time Frame: 24 hours
|
The International Physical Activity Questionnaire is a measure of physical activity.
|
24 hours
|
|
Change from baseline in Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: Monthly, 0-24 months
|
7-item screening form for Generalized Anxiety Disorder.
|
Monthly, 0-24 months
|
|
Change from baseline in the International Physical Activity Questionnaire (IPAQ)
Time Frame: 12 months
|
The International Physical Activity Questionnaire is a measure of physical activity.
|
12 months
|
|
Change from baseline in the International Physical Activity Questionnaire (IPAQ)
Time Frame: 24 months
|
The International Physical Activity Questionnaire is a measure of physical activity.
|
24 months
|
|
Change from baseline in MINI
Time Frame: Monthly, 0-24 months
|
The Mini International Neuropsychiatric Interview is a short, structured interview designed for clinicians to diagnose axel I DSM-IV and ICD-10 disorders.
|
Monthly, 0-24 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ACTUA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
-
Bekelu Teka WorkuJimma UniversityNot yet recruitingPrenatal Depression | Mental Health Related Quality of Life | Maternal Postpartum Depression | Paternal Postpartum DepressionEthiopia
Clinical Trials on Physical activity without motivational interviewing
-
University of Roma La SapienzaUniversity of Rome Tor VergataCompletedHealthy | Physical Activity | Virtual Reality | Older Adults (65 Years and Older)Italy
-
Université Sorbonne Paris NordLigue contre le cancer, France; Garmin International; StimulabRecruitingBreast Cancer | Lung Cancer | Prostate Cancer | Colo-rectal CancerFrance
-
Massachusetts General HospitalNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...Completed
-
Oakland UniversityCompletedMultiple SclerosisUnited States
-
Saltuklu Aile Sağlığı MerkeziNot yet recruitingObesity | Motivational Interviewing | Overweight (BMI > 25) | Eating Behavior Disorders | Cardiometabolic Index | Anthropometric Measurements
-
VA Office of Research and DevelopmentCompletedPhysical Deconditioning | MultimorbidityUnited States
-
Universidad Miguel Hernandez de ElcheUniversidad Europea de Madrid; Fundacion MAPFRECompleted
-
University of Maryland, BaltimoreMaryland Department of Health and Mental HygieneCompletedFractures, Bone | Smoking, TobaccoUnited States
-
University of AarhusUnknown
-
Johns Hopkins UniversityZanvyl and Isabelle Krieger FundCompleted